Q4 2021 Holdings
Filed 2022-02-14 | 53 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $282.0M | 7,566,292 | 27.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $169.6M | 1,000,000 | 16.4% |
| Codexis Inc(CDXS) | COM | 192005106 | $135.4M | 4,330,000 | 13.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $68.7M | 2,090,000 | 6.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $65.3M | 818,820 | 6.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $63.3M | 7,718,593 | 6.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $52.5M | 1,153,335 | 5.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $50.9M | 3,206,380 | 4.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $40.6M | 150,000 | 3.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $39.5M | 2,650,000 | 3.8% |
| Alector Inc(ALEC) | COM | 014442107 | $34.1M | 1,650,000 | 3.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $28.1M | 1,000,000 | 2.7% |
| Eqrx Inc | COM | 26886C107 | $269.6K | 39,527,669 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $198.9K | 3,400,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $186.4K | 12,203,669 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $166.0K | 1,550,000 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $163.5K | 7,990,652 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $158.8K | 2,040,000 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $144.2K | 12,389,082 | 0.0% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $142.4K | 13,971,334 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $121.6K | 1,350,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $118.5K | 3,857,253 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $115.7K | 3,138,167 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $79.0K | 790,000 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $68.0K | 3,586,818 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $66.9K | 1,500,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $60.0K | 5,487,910 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $59.7K | 2,370,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $51.9K | 670,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $38.8K | 1,325,000 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CL A SHS | 37611X100 | $36.0K | 4,328,891 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $27.6K | 1,745,000 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $22.4K | 1,800,000 | 0.0% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $22.3K | 5,000,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $20.2K | 266,430 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $19.6K | 960,882 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $18.2K | 800,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $17.3K | 3,901,589 | 0.0% |
| Singular Genomics Systems in | COM | 82933R100 | $16.7K | 1,442,870 | 0.0% |
| Exscientia PLC | ADS | 30223G102 | $14.1K | 713,900 | 0.0% |
| 23Andme Holding Co | CLASS A COM | 90138Q108 | $12.3K | 1,841,457 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $12.2K | 555,455 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $10.5K | 406,502 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $9.4K | 150,000 | 0.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $9.4K | 548,156 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $9.4K | 1,324,275 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.8K | 601,515 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $7.9K | 583,436 | 0.0% |
| Decibel Therapeutics Inc | COM | 24343R106 | $5.4K | 1,170,048 | 0.0% |
| Berkeley LTS Inc(BLIUSD) | COM | 084310101 | $3.6K | 200,000 | 0.0% |